I can extract side effects

Sheng Changya's attitude made Wei Kang very satisfied.

He thought for a while, and ordered: "Then use money to open the way first, cultivate a few media of your own, and start with mastering the right to speak."

"Don't you know a lot of Internet celebrities? You seem to have a good network in the entertainment industry. You can support some people, both at home and abroad, and let them publish more articles and videos. You must have more language versions."

"As for the theme, the people of the Eagle Country use too much electricity, causing the icebergs at the poles to melt and the sea level to rise. The people of the Eagle Country eat seafood and eat up the ocean. This will lead to the extinction of wild animals, and the rich people in the West will buy ivory and the dark trade of poaching elephants will start."

"Whether it's a video or an article, it must be well-founded, touching, and thought-provoking. It is best to let the white up masters reflect deeply, and the effect will be the best."

"Then let's work it out and win a few more documentaries or video awards. There should be many parallel import awards at home and abroad. Anyway, it will increase the reputation and buy some trending searches so that domestic people and overseas people can understand. one time."

"Anyway, we don't speak out about these things, and the other party is always smearing us. Why don't we jump out and talk nonsense, but the other party can't prove it, and can only catch it blind."

"At that time, the two sides will compete against each other, not only will there be heat, but it will also be easier for the truth to surface, and the truth will become clearer and clearer."

"It's really not good, let's muddy the head office and make everyone think these claims are nonsense, so that no matter what the other side says, no one will believe it, and it will only provoke ridicule. Ha ha."

"Well, everything is difficult at the beginning. Let's start with the online media. It should be easier, and it is also in line with the current publicity boom."

"For the specific content, you can make your own plan, and just show me the finished product later."

"I believe that with your marketing ability, you will be able to successfully achieve your goals."

Sheng Changya listened while taking notes, her expression on her face changed from thoughtful to suddenly enlightened, and finally she applauded excitedly.

"Boss, you are so good. Listening to what you say is better than reading ten years of books. I have fully understood your intentions and will not let you down. I will contact those up masters in a while and be a A detailed plan, and then I will show you the results."

Wei Kang said approvingly, "That's right, it's really easy to talk to smart people. I'll wait for your good news."

After Sheng Changya left, he called Zhang Chunming, the person in charge of Feizhou, and talked for several hours.

Confess your intentions and appoint the other person as the new head of the charity.

Zhang Chunming is very excited about this appointment. In fact, he has long been displeased with those charities in the West.

In addition to being unreasonably reprimanded at the procurement bidding meeting, he also often feels the malice of these charities in his usual operations.

It's just that the other party has been operating for many years and penetrates everywhere. He can't resist for a while, so he can only swallow his anger.

Now Sanqing’s drugs are getting more and more famous and their sales are getting higher and higher, and they are well recognized by the Filipino people.

The headquarters also set up a separate charity organization in the Philippines for him to take charge of, which undoubtedly has a lot to do.

"Mr. Wei, thank you for your trust. I will definitely live up to the trust and achieve results as soon as possible."

Zhang Chunming was so excited, he had countless ideas in his mind instantly, as long as he planned well, several of them could be developed into good plans.

Wei Kang urged: "Very well, remember who our opponent is, and we must unite all Chinese pharmaceutical companies in the Philippines to cooperate with each other for mutual benefit."

"I remember that several pharmaceutical companies already have their own factories in the Philippines. We can cooperate with them to produce some generic drugs on an OEM basis. This should comply with relevant preferential policies, which can reduce a lot of taxes and reduce the costs of some countries. Purchasing Threshold."

"The local Chinese also have their own chambers of commerce. You have to establish a good relationship with them and be their solid backing."

"In short, what Western charities can do, we can do too."

Zhang Chunming nodded, patted his chest and agreed.

After hanging up the phone, Wei Kang picked up the water glass on the table and moistened his throat.

Suddenly, a notification popped up on the computer on the desk.

It turns out that the antihypertensive drug and two antithrombotic drugs have already submitted the clinical phase III trial report, and passed the approval of the Food and Drug Administration, and can be officially launched.

Weikang couldn't help being overjoyed. These three cardiovascular and cerebrovascular disease drugs have excellent efficacy and few side effects. Compared with the same type of competing products on the market, they have great advantages.

He placed high hopes on it, hoping to become Sanqing's leading product in this field.

Especially the anticoagulant drug, the standard apixaban, so the double-blind experiment of the control group was also carried out during the third phase of the clinical trial.

After the experiment, the comparison with competing products is very clear. Not only is the drug effect better at the same dose, but there are also fewer adverse reactions, and it does not affect the taking of other drugs.

Generally speaking, for long-term drugs such as antihypertensive drugs, the time for clinical trials will be longer, and safety considerations are very important.

Because there are already cheap and safe first-line drugs on the market, if new products are to be launched, they must have stronger advantages than existing drugs.

One of the most important advantages of the three drugs of Sanqing is that they have very few adverse reactions and basically do not interact with other drugs, making them safer to take.

Only in this way can it pass the listing approval of the Food and Drug Administration at the fastest speed.

In this way, it took almost a year, which is already a long time compared with the marketing time of other Sanqing drugs.

You must know that most users of cardiovascular and cerebrovascular drugs are middle-aged and elderly people. They usually have several underlying diseases and need to take a lot of medicines. Many elderly people can’t remember the medicines they take every day. eight kinds.

Under such circumstances, the degree of tolerance to adverse reactions is an important basis for drug selection.

If a patient cannot tolerate a certain drug because of too many side effects, the choice will be reduced.

At the same time, patients are taking so many drugs at the same time, and the interaction between drugs is likely to lead to unexpected and extremely dangerous results.

Drug interaction is difficult to test in clinical trials, because the situation is controllable during the trial stage, but after it is launched on the market, the number of people taking it will increase sharply, and the situation of taking other drugs at the same time is inevitable.

Drug-drug interactions are one of the most common reasons for withdrawal of approved drugs.

Even the pharmaceutical giants will inevitably stumble in this regard and pay a heavy price.

Bayer once had a lipid-lowering drug that was withdrawn after a few years after it was launched in Eagle Country, it discovered a serious side effect in muscle tissue.

The lipid-lowering drug, Baycol, is often used in combination with another lipid-lowering drug, gemfibrozil, when used in elderly patients, and the interaction of the two drugs can lead to fatal rhabdomyolysis.

Before Bayer officially withdrew the drug, there were more than 30 deaths caused by rhabdomyolysis in Eagle Country alone.

A drug interaction like this is very dangerous because it can dramatically alter the effective dose of a drug and its residence time in a patient's body, leading to unpredictable and dire consequences.

The three drugs of Sanqing passed the fast application channel so smoothly because of their high scores in safety.

Soon, Sanqing officially announced its entry into the field of cardiovascular drugs, and announced the launch time of these three drugs.

The news quickly attracted widespread attention from peers.

At present, there are only three or four well-known companies in cardiovascular disease research in the world, including Merck, AstraZeneca, Pfizer and Novartis.

They cast defensive eyes on Sanqing one after another, and became a little wary of the new competitors.

Sanqing's impressive record is enough to prove its own strength. Although the market for cardiovascular drugs is very large, there are many types of drugs and the competition is fierce. After years of fighting, they have long been accustomed to the current division of power.

Now there is another Tyrannosaurus rex that is grabbing food, which is bound to set off a bloody storm in this field.